Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLAG-Ida with G-CSF Priming in Resistant AML
NCT00559221Phase 2Unknown
- Sponsor
- Japan Adult Leukemia Study Group
- Start
- Dec 2004
- Modality
- Orthosteric Ligands, Cytokines & Interferons, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of fludarabine, cytarabine, idarubicin, filgrastim in acute myeloid leukemia (AML), sponsored by Japan Adult Leukemia Study Group. Status: unknown.
02
Drugs
fludarabinecytarabineidarubicinfilgrastim
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00559221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00559221.